Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Tamiflu
Generic name / active ingredient
oseltamivir
Dosage-form class
Oral capsules and powder for oral suspension (after reconstitution), as listed in the 2025 DailyMed label
Route
Oral
Record reviewed
2026-08-21

Copy from the pack in hand

Source-linked reading points

  • Read brand, generic name, dosage form and strength together. Milligrams on a capsule and the concentration, measuring device and volume of a suspension are not the same information; sharing oseltamivir does not permit self-conversion from “capsules” to “millilitres” or back.
  • Flu-like symptoms, age, weight, kidney function, time since symptoms began, the actual product and local label all affect how professionals review a prescription. This page does not decide whether or when to start, make up a use, or give leftover medicine to another family member.
  • TAMIFLU identifies an influenza antiviral product; it does not establish that a common cold, bacterial infection or every fever and cough can be self-managed by replacing an antibiotic or another medicine. Fever, cough/cold, chronic-care and supplement products should be reviewed together as a complete medicine list.
  • With breathing difficulty, altered awareness, inability to eat or drink, continued deterioration, or uncertainty about dosage form, measuring device or label, use timely local medical and professional support; this page does not replace assessment of acute illness.

Reviewed presentation examples — compare every field

  • 75 mg per capsule; 10-capsule blister-card cartonNDC 0004-0800-85
  • 6 mg/mL; 60 mL usable reconstituted oral-suspension bottleNDC 0004-0822-05

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-21
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image